These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22710483)

  • 1. Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.
    Turkbey EB; Gai N; Lima JA; van der Geest RJ; Wagner KR; Tomaselli GF; Bluemke DA; Nazarian S
    Heart Rhythm; 2012 Oct; 9(10):1691-7. PubMed ID: 22710483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
    Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
    Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
    Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
    Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique.
    Nii M; Ishida M; Dohi K; Tanaka H; Kondo E; Ito M; Sakuma H; Ikeda T
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):52. PubMed ID: 30068369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study.
    Donekal S; Venkatesh BA; Liu YC; Liu CY; Yoneyama K; Wu CO; Nacif M; Gomes AS; Hundley WG; Bluemke DA; Lima JA
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):292-302. PubMed ID: 24550436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness.
    Ellims AH; Shaw JA; Stub D; Iles LM; Hare JL; Slavin GS; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2014 Mar; 63(11):1112-8. PubMed ID: 24518490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot.
    Yim D; Riesenkampff E; Caro-Dominguez P; Yoo SJ; Seed M; Grosse-Wortmann L
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
    Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
    Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
    Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
    Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy.
    Kashyap N; Nikhanj A; Labib D; Prosia E; Rivest S; Flewitt J; Pfeffer G; Bakal JA; Siddiqi ZA; Coulden RA; Thompson R; White JA; Oudit GY
    J Am Heart Assoc; 2023 Nov; 12(21):e030229. PubMed ID: 37929714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.